53rd World Health Assembly presided over by Dr. Libertina Amathila (Namibia) endorsed “Global strategy for non-communicable disease (NCD) prevention and control,” which outlined major objectives for monitoring, preventing, and managing NCDs, with special emphasis on major NCDs with common risk factors and determi- nants— cardiovascular disease, cancer, diabetes, and chronic respiratory disease.
The entire human genome is mapped.
Charter of Paris against Cancer is signed.
International Childhood Cancer Day was launched, its aim to raise awareness of the 250,000 children worldwide who get cancer every year. Some 80% of these children have little or no access to treatment. The first annual event in 2002 was supported in 30 countries around the world and raised over US$100,000 for parent organizations to help children in their own countries.
WHO cancer prevention and control resolution approved by World Health Assembly.
WHO Framework Convention on Tobacco Control came into force, using international law to further public health and prevent cancer.
The US Federal Drug Administration approved the first HPV vaccine to prevent infections that cause cervical cancer.
Lung cancer deaths reduced by low-dose computed tomography (CT) scanning of people at high risk.
UN High Level Meeting on Non-communicable Diseases in New York, USA.
The US FDA approved sofosbuvir for use in combination with other agents for the treatment of chronic HCV infection in adults, reducing treatment time and toxicity compared with earlier treatments and increasing cure rates to more than 80%.
A goal to reduce premature mortality from NCDs including cancer by one-third by 2030 was added to the United Nations Development Programme’s Sustainable Development Goals.
Achievement of universal health coverage, including financial risk protection, access to quality essential health-care services and access to safe, effective, quality and affordable essential medicines and vaccines for all, was added to the United Nations Sustainable Development Goals.
The US FDA approved the first adoptive cell immunotherapy, also known as chimeric antigen receptor (CAR) T-cell therapy.
The World Health Assembly of the World Health Organization renewed its commitment to cancer prevention and control through the adoption of a resolution providing countries with guidance for health promotion and risk factor reduction, with particular emphasis on the tobacco control policies laid out in the Framework Convention on Tobacco Control and anti-cancer vaccines, but also the need to address inequity in access to early detection and timely and appropriate treatment, including pain relief and palliative care.
World Health Organization Director General Dr. Tedros Adhanom Ghebreyesus calls for coordinated global action for the elimination of cervical cancer.
The World Health Organization announces the Global Initiative for Childhood Cancer with the aim of reaching at least a 60% survival rate for children with cancer by 2030, representing a doubling of the global cure rate for children with cancer.